Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 43 entries
Sorted by: Best Match Show Resources per page
Induction with Rabbit Antithymocyte Globulin following Orthotopic Liver Transplantation for Hepatitis C.

International journal of organ transplantation medicine

Saidi RF, Hertl M, Chung RT, Ko DS, Kawai T, Markmann J, Bhan AK, Cosimi AB, Elias N.
PMID: 25013609
Int J Organ Transplant Med. 2011;2(4):160-5.

BACKGROUND: Hepatitis C (HCV) is the most common indication for liver transplantation in the US.OBJECTIVE: Since steroids are the major stimulus of viral replication, we postulated that steroid-free immunosuppression might be a safer approach.METHODS: From January 1995 to October...

Cite
Saidi RF, Hertl M, Chung RT, et al. Induction with Rabbit Antithymocyte Globulin following Orthotopic Liver Transplantation for Hepatitis C. Int J Organ Transplant Med. 2011;2(4):160-5
Saidi, R. F., Hertl, M., Chung, R. T., Ko, D. S., Kawai, T., Markmann, J., Bhan, A. K., Cosimi, A. B., & Elias, N. (2011). Induction with Rabbit Antithymocyte Globulin following Orthotopic Liver Transplantation for Hepatitis C. International journal of organ transplantation medicine, 2(4), 160-5.
Saidi, R F, et al. "Induction with Rabbit Antithymocyte Globulin following Orthotopic Liver Transplantation for Hepatitis C." International journal of organ transplantation medicine vol. 2,4 (2011): 160-5.
Saidi RF, Hertl M, Chung RT, Ko DS, Kawai T, Markmann J, Bhan AK, Cosimi AB, Elias N. Induction with Rabbit Antithymocyte Globulin following Orthotopic Liver Transplantation for Hepatitis C. Int J Organ Transplant Med. 2011;2(4):160-5. PMID: 25013609; PMCID: PMC4089267.
Copy Download .nbib Format: NLM
Live donor partial hepatectomy for liver transplantation: is there a learning curve?.

International journal of organ transplantation medicine

Saidi RF, Elias N, Ko DS, Kawai T, Markmann J, Feng S, Cosimi AB, Hertl M.
PMID: 25013578
Int J Organ Transplant Med. 2010;1(3):125-30.

BACKGROUND: Donor safety is the first priority in living donor liver transplantation (LDLT).OBJECTIVE: To determine the characteristics and outcome of live liver donors who underwent donor hepatectomy from January, 1997 to May, 2007 at Massachusetts General Hospital.METHODS: 30 patients...

Cite
Saidi RF, Elias N, Ko DS, et al. Live donor partial hepatectomy for liver transplantation: is there a learning curve?. Int J Organ Transplant Med. 2010;1(3):125-30
Saidi, R. F., Elias, N., Ko, D. S., Kawai, T., Markmann, J., Feng, S., Cosimi, A. B., & Hertl, M. (2010). Live donor partial hepatectomy for liver transplantation: is there a learning curve?. International journal of organ transplantation medicine, 1(3), 125-30.
Saidi, R F, et al. "Live donor partial hepatectomy for liver transplantation: is there a learning curve?." International journal of organ transplantation medicine vol. 1,3 (2010): 125-30.
Saidi RF, Elias N, Ko DS, Kawai T, Markmann J, Feng S, Cosimi AB, Hertl M. Live donor partial hepatectomy for liver transplantation: is there a learning curve?. Int J Organ Transplant Med. 2010;1(3):125-30. PMID: 25013578; PMCID: PMC4089236.
Copy Download .nbib Format: NLM
Elevated peripheral neutrophils and matrix metalloproteinase 9 as biomarkers of functional outcome following subarachnoid hemorrhage.

Translational stroke research

Chou SH, Feske SK, Simmons SL, Konigsberg RG, Orzell SC, Marckmann A, Bourget G, Bauer DJ, De Jager PL, Du R, Arai K, Lo EH, Ning MM.
PMID: 22207885
Transl Stroke Res. 2011 Dec;2(4):600-7. doi: 10.1007/s12975-011-0117-x. Epub 2011 Nov 10.

There is growing evidence supporting the role of inflammation in early brain injury and cerebral vasospasm following subarachnoid hemorrhage (SAH). Matrix metalloproteinases (MMPs) are released by inflammatory cells and can mediate early brain injury via disruption of the extracellular...

Cite
Chou SH, Feske SK, Simmons SL, et al. Elevated peripheral neutrophils and matrix metalloproteinase 9 as biomarkers of functional outcome following subarachnoid hemorrhage. Transl Stroke Res. 2011;2(4):600-7doi: 10.1007/s12975-011-0117-x.
Chou, S. H., Feske, S. K., Simmons, S. L., Konigsberg, R. G., Orzell, S. C., Marckmann, A., Bourget, G., Bauer, D. J., De Jager, P. L., Du, R., Arai, K., Lo, E. H., & Ning, M. M. (2011). Elevated peripheral neutrophils and matrix metalloproteinase 9 as biomarkers of functional outcome following subarachnoid hemorrhage. Translational stroke research, 2(4), 600-7. https://doi.org/10.1007/s12975-011-0117-x
Chou, S H-Y, et al. "Elevated peripheral neutrophils and matrix metalloproteinase 9 as biomarkers of functional outcome following subarachnoid hemorrhage." Translational stroke research vol. 2,4 (2011): 600-7. doi: https://doi.org/10.1007/s12975-011-0117-x
Chou SH, Feske SK, Simmons SL, Konigsberg RG, Orzell SC, Marckmann A, Bourget G, Bauer DJ, De Jager PL, Du R, Arai K, Lo EH, Ning MM. Elevated peripheral neutrophils and matrix metalloproteinase 9 as biomarkers of functional outcome following subarachnoid hemorrhage. Transl Stroke Res. 2011 Dec;2(4):600-7. doi: 10.1007/s12975-011-0117-x. Epub 2011 Nov 10. PMID: 22207885; PMCID: PMC3236293.
Copy Download .nbib Format: NLM
Erratum for Markmann et al., "Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals".

mSphere

Markmann AJ, Giallourou N, Bhowmik DR, Hou YJ, Lerner A, Martinez DR, Premkumar L, Root H, van Duin D, Napravnik S, Graham SD, Guerra Q, Raut R, Petropoulos CJ, Wrin T, Cornaby C, Schmitz J, Kuruc J, Weiss S, Park Y, Baric R, de Silva AM, Margolis DM, Bartelt LA.
PMID: 34494885
mSphere. 2021 Oct 27;6(5):e0073621. doi: 10.1128/mSphere.00736-21. Epub 2021 Sep 08.

No abstract available.

Cite
Markmann AJ, Giallourou N, Bhowmik DR, et al. Erratum for Markmann et al., "Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals". mSphere. 2021;6(5):e0073621doi: 10.1128/mSphere.00736-21.
Markmann, A. J., Giallourou, N., Bhowmik, D. R., Hou, Y. J., Lerner, A., Martinez, D. R., Premkumar, L., Root, H., van Duin, D., Napravnik, S., Graham, S. D., Guerra, Q., Raut, R., Petropoulos, C. J., Wrin, T., Cornaby, C., Schmitz, J., Kuruc, J., Weiss, S., Park, Y., Baric, R., de Silva, A. M., Margolis, D. M., & Bartelt, L. A. (2021). Erratum for Markmann et al., "Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals". mSphere, 6(5), e0073621. https://doi.org/10.1128/mSphere.00736-21
Markmann, Alena J, et al. "Erratum for Markmann et al., "Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals"." mSphere vol. 6,5 (2021): e0073621. doi: https://doi.org/10.1128/mSphere.00736-21
Markmann AJ, Giallourou N, Bhowmik DR, Hou YJ, Lerner A, Martinez DR, Premkumar L, Root H, van Duin D, Napravnik S, Graham SD, Guerra Q, Raut R, Petropoulos CJ, Wrin T, Cornaby C, Schmitz J, Kuruc J, Weiss S, Park Y, Baric R, de Silva AM, Margolis DM, Bartelt LA. Erratum for Markmann et al., "Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals". mSphere. 2021 Oct 27;6(5):e0073621. doi: 10.1128/mSphere.00736-21. Epub 2021 Sep 08. PMID: 34494885; PMCID: PMC8550153.
Copy Download .nbib Format: NLM
Disparities in SARS-CoV-2 seroprevalence among individuals presenting for care in central North Carolina over a six-month period.

medRxiv : the preprint server for health sciences

Lopez CA, Cunningham CH, Pugh S, Brandt K, Vanna UP, Delacruz MJ, Guerra Q, Goldstein SJ, Hou YJ, Gearhart M, Wiethorn C, Pope C, Amditis C, Pruitt K, Newberry-Dillon C, Schmitz J, Premkumar L, Adimora AA, Emch M, Boyce R, Aiello AE, Fosdick BK, Larremore DB, de Silva AM, Juliano JJJ, Markmann AJ.
PMID: 33791743
medRxiv. 2021 Mar 30; doi: 10.1101/2021.03.25.21254320.

Robust community-level SARS-CoV-2 prevalence estimates have been difficult to obtain in the American South and outside of major metropolitan areas. Furthermore, though some previous studies have investigated the association of demographic factors such as race with SARS-CoV-2 exposure risk,...

Cite
Lopez CA, Cunningham CH, Pugh S, et al. Disparities in SARS-CoV-2 seroprevalence among individuals presenting for care in central North Carolina over a six-month period. medRxiv. 2021;doi: 10.1101/2021.03.25.21254320.
Lopez, C. A., Cunningham, C. H., Pugh, S., Brandt, K., Vanna, U. P., Delacruz, M. J., Guerra, Q., Goldstein, S. J., Hou, Y. J., Gearhart, M., Wiethorn, C., Pope, C., Amditis, C., Pruitt, K., Newberry-Dillon, C., Schmitz, J., Premkumar, L., Adimora, A. A., Emch, M., Boyce, R., Aiello, A. E., Fosdick, B. K., Larremore, D. B., de Silva, A. M., Juliano, J. J. J., & Markmann, A. J. (2021). Disparities in SARS-CoV-2 seroprevalence among individuals presenting for care in central North Carolina over a six-month period. medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2021.03.25.21254320
Lopez, Cesar A, et al. "Disparities in SARS-CoV-2 seroprevalence among individuals presenting for care in central North Carolina over a six-month period." medRxiv : the preprint server for health sciences vol. (2021). doi: https://doi.org/10.1101/2021.03.25.21254320
Lopez CA, Cunningham CH, Pugh S, Brandt K, Vanna UP, Delacruz MJ, Guerra Q, Goldstein SJ, Hou YJ, Gearhart M, Wiethorn C, Pope C, Amditis C, Pruitt K, Newberry-Dillon C, Schmitz J, Premkumar L, Adimora AA, Emch M, Boyce R, Aiello AE, Fosdick BK, Larremore DB, de Silva AM, Juliano JJJ, Markmann AJ. Disparities in SARS-CoV-2 seroprevalence among individuals presenting for care in central North Carolina over a six-month period. medRxiv. 2021 Mar 30; doi: 10.1101/2021.03.25.21254320. PMID: 33791743; PMCID: PMC8010775.
Copy Download .nbib Format: NLM
Advancing Germany's new global health strategy.

BMJ global health

Stratil JM, von Philipsborn P, Marckmann G, Pfadenhauer LM, Zeeb H, Rehfuess EA.
PMID: 30613429
BMJ Glob Health. 2018 Dec 10;3(6):e001140. doi: 10.1136/bmjgh-2018-001140. eCollection 2018.

No abstract available.

Cite
Stratil JM, von Philipsborn P, Marckmann G, et al. Advancing Germany's new global health strategy. BMJ Glob Health. 2018;3(6):e001140doi: 10.1136/bmjgh-2018-001140.
Stratil, J. M., von Philipsborn, P., Marckmann, G., Pfadenhauer, L. M., Zeeb, H., & Rehfuess, E. A. (2018). Advancing Germany's new global health strategy. BMJ global health, 3(6), e001140. https://doi.org/10.1136/bmjgh-2018-001140
Stratil, Jan M, et al. "Advancing Germany's new global health strategy." BMJ global health vol. 3,6 (2018): e001140. doi: https://doi.org/10.1136/bmjgh-2018-001140
Stratil JM, von Philipsborn P, Marckmann G, Pfadenhauer LM, Zeeb H, Rehfuess EA. Advancing Germany's new global health strategy. BMJ Glob Health. 2018 Dec 10;3(6):e001140. doi: 10.1136/bmjgh-2018-001140. eCollection 2018. PMID: 30613429; PMCID: PMC6304092.
Copy Download .nbib Format: NLM
[Correction: Advance Care Planning and its Relevance for Emergency and Intensive Care Medicine].

Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS

Nauck F, Marckmann G, In der Schmitten J.
PMID: 29548041
Anasthesiol Intensivmed Notfallmed Schmerzther. 2018 Jan;53(1):e1. doi: 10.1055/a-0591-7094. Epub 2018 Mar 16.

No abstract available.

Cite
Nauck F, Marckmann G, In der Schmitten J. Erratum: Behandlung im Voraus planen – Bedeutung für die Intensiv- und Notfallmedizin. [Correction: Advance Care Planning and its Relevance for Emergency and Intensive Care Medicine]. Anasthesiol Intensivmed Notfallmed Schmerzther. 2018;53(1):e1doi: 10.1055/a-0591-7094.
Nauck, F., Marckmann, G., & In der Schmitten, J. (2018). Erratum: Behandlung im Voraus planen – Bedeutung für die Intensiv- und Notfallmedizin. [Correction: Advance Care Planning and its Relevance for Emergency and Intensive Care Medicine]. Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 53(1), e1. https://doi.org/10.1055/a-0591-7094
Nauck, Friedemann, et al. "Erratum: Behandlung im Voraus planen – Bedeutung für die Intensiv- und Notfallmedizin." [Correction: Advance Care Planning and its Relevance for Emergency and Intensive Care Medicine]. Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS vol. 53,1 (2018): e1. doi: https://doi.org/10.1055/a-0591-7094
Nauck F, Marckmann G, In der Schmitten J. Erratum: Behandlung im Voraus planen – Bedeutung für die Intensiv- und Notfallmedizin. [Correction: Advance Care Planning and its Relevance for Emergency and Intensive Care Medicine]. Anasthesiol Intensivmed Notfallmed Schmerzther. 2018 Jan;53(1):e1. doi: 10.1055/a-0591-7094. Epub 2018 Mar 16. German. PMID: 29548041.
Copy Download .nbib Format: NLM
Biliary reconstruction and complications after living-donor liver transplantation.

HPB : the official journal of the International Hepato Pancreato Biliary Association

Saidi RF, Elias N, Ko DS, Kawai T, Markmann J, Cosimi AB, Hertl M.
PMID: 19816615
HPB (Oxford). 2009 Sep;11(6):505-9. doi: 10.1111/j.1477-2574.2009.00093.x.

BACKGROUND: The technique of biliary reconstruction remains controversial in living-donor liver transplantation (LDLT). The objective of this study was to assess the incidence of biliary complications after LDLT based on the reconstruction technique.METHODS: Between 1997 and 2007, 30 patients...

Cite
Saidi RF, Elias N, Ko DS, et al. Biliary reconstruction and complications after living-donor liver transplantation. HPB (Oxford). 2009;11(6):505-9doi: 10.1111/j.1477-2574.2009.00093.x.
Saidi, R. F., Elias, N., Ko, D. S., Kawai, T., Markmann, J., Cosimi, A. B., & Hertl, M. (2009). Biliary reconstruction and complications after living-donor liver transplantation. HPB : the official journal of the International Hepato Pancreato Biliary Association, 11(6), 505-9. https://doi.org/10.1111/j.1477-2574.2009.00093.x
Saidi, Reza F, et al. "Biliary reconstruction and complications after living-donor liver transplantation." HPB : the official journal of the International Hepato Pancreato Biliary Association vol. 11,6 (2009): 505-9. doi: https://doi.org/10.1111/j.1477-2574.2009.00093.x
Saidi RF, Elias N, Ko DS, Kawai T, Markmann J, Cosimi AB, Hertl M. Biliary reconstruction and complications after living-donor liver transplantation. HPB (Oxford). 2009 Sep;11(6):505-9. doi: 10.1111/j.1477-2574.2009.00093.x. PMID: 19816615; PMCID: PMC2756638.
Copy Download .nbib Format: NLM
Preparing n-of-1 Antisense Oligonucleotide Treatments for Rare Neurological Diseases in Europe: Genetic, Regulatory, and Ethical Perspectives.

Nucleic acid therapeutics

Synofzik M, van Roon-Mom WMC, Marckmann G, van Duyvenvoorde HA, Graessner H, Schüle R, Aartsma-Rus A.
PMID: 34591693
Nucleic Acid Ther. 2021 Sep 29; doi: 10.1089/nat.2021.0039. Epub 2021 Sep 29.

Antisense oligonucleotide (ASO) therapies present a promising disease-modifying treatment approach for rare neurological diseases (RNDs). However, the current focus is on "more common" RNDs, leaving a large share of RND patients still without prospect of disease-modifying treatments. In response...

Cite
Synofzik M, van Roon-Mom WMC, Marckmann G, et al. Preparing n-of-1 Antisense Oligonucleotide Treatments for Rare Neurological Diseases in Europe: Genetic, Regulatory, and Ethical Perspectives. Nucleic Acid Ther. 2021;doi: 10.1089/nat.2021.0039.
Synofzik, M., van Roon-Mom, W. M. C., Marckmann, G., van Duyvenvoorde, H. A., Graessner, H., Schüle, R., & Aartsma-Rus, A. (2021). Preparing n-of-1 Antisense Oligonucleotide Treatments for Rare Neurological Diseases in Europe: Genetic, Regulatory, and Ethical Perspectives. Nucleic acid therapeutics, . https://doi.org/10.1089/nat.2021.0039
Synofzik, Matthis, et al. "Preparing n-of-1 Antisense Oligonucleotide Treatments for Rare Neurological Diseases in Europe: Genetic, Regulatory, and Ethical Perspectives." Nucleic acid therapeutics vol. (2021). doi: https://doi.org/10.1089/nat.2021.0039
Synofzik M, van Roon-Mom WMC, Marckmann G, van Duyvenvoorde HA, Graessner H, Schüle R, Aartsma-Rus A. Preparing n-of-1 Antisense Oligonucleotide Treatments for Rare Neurological Diseases in Europe: Genetic, Regulatory, and Ethical Perspectives. Nucleic Acid Ther. 2021 Sep 29; doi: 10.1089/nat.2021.0039. Epub 2021 Sep 29. PMID: 34591693.
Copy Download .nbib Format: NLM
Putting public health ethics into practice: a systematic framework.

Frontiers in public health

Marckmann G, Schmidt H, Sofaer N, Strech D.
PMID: 25705615
Front Public Health. 2015 Feb 06;3:23. doi: 10.3389/fpubh.2015.00023. eCollection 2015.

It is widely acknowledged that public health practice raises ethical issues that require a different approach than traditional biomedical ethics. Several frameworks for public health ethics (PHE) have been proposed; however, none of them provides a practice-oriented combination of...

Cite
Marckmann G, Schmidt H, Sofaer N, et al. Putting public health ethics into practice: a systematic framework. Front Public Health. 2015;3:23doi: 10.3389/fpubh.2015.00023.
Marckmann, G., Schmidt, H., Sofaer, N., & Strech, D. (2015). Putting public health ethics into practice: a systematic framework. Frontiers in public health, 323. https://doi.org/10.3389/fpubh.2015.00023
Marckmann, Georg, et al. "Putting public health ethics into practice: a systematic framework." Frontiers in public health vol. 3 (2015): 23. doi: https://doi.org/10.3389/fpubh.2015.00023
Marckmann G, Schmidt H, Sofaer N, Strech D. Putting public health ethics into practice: a systematic framework. Front Public Health. 2015 Feb 06;3:23. doi: 10.3389/fpubh.2015.00023. eCollection 2015. PMID: 25705615; PMCID: PMC4319377.
Copy Download .nbib Format: NLM
Organ transplants of the future: planning for innovations including xenotransplantation.

Transplant international : official journal of the European Society for Organ Transplantation

Cozzi E, Schneeberger S, Bellini MI, Berglund E, Böhmig G, Fowler K, Hoogduijn M, Jochmans I, Marckmann G, Marson L, Neuberger J, Oberbauer R, Pierson RN, Reichart B, Scobie L, White C, Naesens M.
PMID: 34459040
Transpl Int. 2021 Nov;34(11):2006-2018. doi: 10.1111/tri.14031. Epub 2021 Oct 06.

The future clinical application of animal-to-human transplantation (xenotransplantation) is of importance to society as a whole. Favourable preclinical data relevant to cell, tissue and solid organ xenotransplants have been obtained from many animal models utilizing genetic engineering and protocols...

Cite
Cozzi E, Schneeberger S, Bellini MI, et al. Organ transplants of the future: planning for innovations including xenotransplantation. Transpl Int. 2021;34(11):2006-2018doi: 10.1111/tri.14031.
Cozzi, E., Schneeberger, S., Bellini, M. I., Berglund, E., Böhmig, G., Fowler, K., Hoogduijn, M., Jochmans, I., Marckmann, G., Marson, L., Neuberger, J., Oberbauer, R., Pierson, R. N., Reichart, B., Scobie, L., White, C., Naesens, M. (2021). Organ transplants of the future: planning for innovations including xenotransplantation. Transplant international : official journal of the European Society for Organ Transplantation, 34(11), 2006-2018. https://doi.org/10.1111/tri.14031
Cozzi, Emanuele, et al. "Organ transplants of the future: planning for innovations including xenotransplantation." Transplant international : official journal of the European Society for Organ Transplantation vol. 34,11 (2021): 2006-2018. doi: https://doi.org/10.1111/tri.14031
Cozzi E, Schneeberger S, Bellini MI, Berglund E, Böhmig G, Fowler K, Hoogduijn M, Jochmans I, Marckmann G, Marson L, Neuberger J, Oberbauer R, Pierson RN, Reichart B, Scobie L, White C, Naesens M. Organ transplants of the future: planning for innovations including xenotransplantation. Transpl Int. 2021 Nov;34(11):2006-2018. doi: 10.1111/tri.14031. Epub 2021 Oct 06. PMID: 34459040.
Copy Download .nbib Format: NLM
Long-term predictors of loss of asthma control in school-aged well-controlled children with mild to moderate asthma: A 5-year follow-up.

Pediatric pulmonology

Hauerslev M, Garpvall K, Marckmann M, Hermansen MN, Hansen KS, Chawes BL.
PMID: 34590793
Pediatr Pulmonol. 2022 Jan;57(1):81-89. doi: 10.1002/ppul.25710. Epub 2021 Oct 05.

BACKGROUND: Long-term follow-up studies establishing risk factors for loss of asthma control in well-controlled children with mild to moderate disease are lacking and are of importance for improving patient quality of life and utilization of health-care resources.METHODS: Loss of...

Cite
Hauerslev M, Garpvall K, Marckmann M, et al. Long-term predictors of loss of asthma control in school-aged well-controlled children with mild to moderate asthma: A 5-year follow-up. Pediatr Pulmonol. 2021;57(1):81-89doi: 10.1002/ppul.25710.
Hauerslev, M., Garpvall, K., Marckmann, M., Hermansen, M. N., Hansen, K. S., & Chawes, B. L. (2022). Long-term predictors of loss of asthma control in school-aged well-controlled children with mild to moderate asthma: A 5-year follow-up. Pediatric pulmonology, 57(1), 81-89. https://doi.org/10.1002/ppul.25710
Hauerslev, Marie, et al. "Long-term predictors of loss of asthma control in school-aged well-controlled children with mild to moderate asthma: A 5-year follow-up." Pediatric pulmonology vol. 57,1 (2022): 81-89. doi: https://doi.org/10.1002/ppul.25710
Hauerslev M, Garpvall K, Marckmann M, Hermansen MN, Hansen KS, Chawes BL. Long-term predictors of loss of asthma control in school-aged well-controlled children with mild to moderate asthma: A 5-year follow-up. Pediatr Pulmonol. 2022 Jan;57(1):81-89. doi: 10.1002/ppul.25710. Epub 2021 Oct 05. PMID: 34590793.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 43 entries